Alia Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alia Ahmed has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
A. Bewley
Department of Dermatology, Royal London Hospital, Whitechapel, London, UK
3 shared publicationsR. Shah
Department of Dermatology, Royal London Hospital, Whitechapel, London, UK
2 shared publicationsAnthony Bewley
Department of Dermatology, Barts Health NHS Trust , London
1 shared publicationIyas Assalman
Department of Psychiatry East London NHS Foundation Trust , London
1 shared publicationJonathan Kentley
Chelsea and Westminster Hospital
1 shared publicationKirsty E. Smith
King Edward VII Hospital, Frimley Health NHS Foundation Trust
1 shared publication
Latest Publications
- Open Access
- 22 August 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (1) , 1-3
‘Psycholag’: a new term to describe the delay between physical and psychological improvement in patients with skin disease
Alia Ahmed, Padma Mohandas, Ruth Taylor, Iyas Assalman, Anthony Bewley; ‘Psycholag’: a new term to describe the delay between physical and psychological im
- 22 August 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (1) , 1-3
Open Access‘Psycholag’: a new term to describe the delay between physical and psychological improvement in patients with skin disease
Alia Ahmed, Padma Mohandas, Ruth Taylor, Iyas Assalman, Anthony Bewley; ‘Psycholag’: a new term to describe the delay between physical and psychological im
- Open Access
- 30 October 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (Supplement) , i1-i2
Resilience in skin disease
The ‘Resilience in Skin Disease’ supplement features three papers that demonstrate how skin is confronting diverse challenges today. These take the form of immune-related adverse events (irAEs) triggered by immune checkpoint inhibitor (ICI) therapy, the ageing process and the psychological sequelae of acne.1–3 Together, the papers remind us not only of the broad range of dermatological afflictions, but also that the impact on the patient – combined with an academic approach – should be fundamental to our work.
- 30 October 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (Supplement) , i1-i2
Open AccessResilience in skin disease
The ‘Resilience in Skin Disease’ supplement features three papers that demonstrate how skin is confronting diverse challenges today. These take the form of immune-related adverse events (irAEs) triggered by immune checkpoint inhibitor (ICI) therapy, the ageing process and the psychological sequelae of acne.1–3 Together, the papers remind us not only of the broad range of dermatological afflictions, but also that the impact on the patient – combined with an academic approach – should be fundamental to our work.
- 14 September 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (6) , e99-e102
Global VALIANT study: ‘lifting the lid’ on disappointment and frustration with the lack of effective treatment for vitiligo
Alia Ahmed, Viktoria Eleftheriadou; Global VALIANT study: “lifting the lid” on disappointment and frustration with lack of effective treatment for vitiligo, Bri
- 14 September 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (6) , e99-e102
Global VALIANT study: ‘lifting the lid’ on disappointment and frustration with the lack of effective treatment for vitiligo
Alia Ahmed, Viktoria Eleftheriadou; Global VALIANT study: “lifting the lid” on disappointment and frustration with lack of effective treatment for vitiligo, Bri
- 4 June 2021
- Published by Springer Nature
- p. 105-123
Eczema and Psychodermatology
- 4 June 2021
- Published by Springer Nature
- p. 233-241
Trigeminal Trophic Syndrome
- 12 May 2015
- Published by Wiley in The Clinical Teacher
- Vol. 13 (1) , 69-71
Are medical students skint on skin?
- 12 May 2015
- Published by Wiley in The Clinical Teacher
- Vol. 13 (1) , 69-71
Are medical students skint on skin?
- 7 March 2015
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (5) , 495-501
An ethnographic study into the psychological impact and adaptive mechanisms of living with hand eczema
Background Hand eczema (HE) severely impairs patients’ quality of life, and causes significant psychological and social distress. There has been little focus on how people with HE perceive their disease and how they may be adapting their behaviours to cope with their condition. Aim A survey was carried out to investigate how the physical and aesthetic impact of HE may affect patients psychologically, and to assess their associated behavioural changes and disease perception. Methods A 22‐item survey covering demographics, disease‐related questions and psychosocial items was completed by patients with HE via a website. Results In total, 1023 people with HE completed the survey. Of these, 89% stated they were embarrassed/self‐conscious about their eczema, with 70% of respondents reporting wearing gloves or hiding their hands in their pockets. Many respondents reported their HE affected their daily activities and choices, with 74% of patients reporting that their condition affects the way they handle objects or touch people. Regarding relationships, 27% of respondents said physical relationships with their partners were affected, and 27% said that tension/disagreements between them and their partner or family/friends occurred because HE had stopped them doing certain activities. Conclusion HE can have a very large psychological impact on sufferers, hugely reducing their self‐esteem, and as a consequence, having a detrimental effect on their daily activities and relationships. The impact of these psychosocial comorbidities has been underinvestigated and often underestimated by clinicians, despite being of great importance to patients.
- 7 March 2015
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (5) , 495-501
An ethnographic study into the psychological impact and adaptive mechanisms of living with hand eczema
Background Hand eczema (HE) severely impairs patients’ quality of life, and causes significant psychological and social distress. There has been little focus on how people with HE perceive their disease and how they may be adapting their behaviours to cope with their condition. Aim A survey was carried out to investigate how the physical and aesthetic impact of HE may affect patients psychologically, and to assess their associated behavioural changes and disease perception. Methods A 22‐item survey covering demographics, disease‐related questions and psychosocial items was completed by patients with HE via a website. Results In total, 1023 people with HE completed the survey. Of these, 89% stated they were embarrassed/self‐conscious about their eczema, with 70% of respondents reporting wearing gloves or hiding their hands in their pockets. Many respondents reported their HE affected their daily activities and choices, with 74% of patients reporting that their condition affects the way they handle objects or touch people. Regarding relationships, 27% of respondents said physical relationships with their partners were affected, and 27% said that tension/disagreements between them and their partner or family/friends occurred because HE had stopped them doing certain activities. Conclusion HE can have a very large psychological impact on sufferers, hugely reducing their self‐esteem, and as a consequence, having a detrimental effect on their daily activities and relationships. The impact of these psychosocial comorbidities has been underinvestigated and often underestimated by clinicians, despite being of great importance to patients.
- 16 June 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 39 (5) , 624-627
Suicide and depression in a patient with psoriasis receiving adalimumab: the role of the dermatologist
A 53‐year‐old man took his own life while receiving biological therapy with the tumour necrosis factor‐α inhibitor adalimumab for severe psoriasis. The patient had a psychiatric history and a 32‐year history of variable unstable psoriasis. Reported suicide in patients with psoriasis receiving adalimumab is rare (only one other reported case). It is important, however, to recognize the effects of skin disease on the mental health of vulnerable patients receiving biological agents. Patients will benefit from a more holistic approach that includes both dermatological and psychological assessment and treatment.
- 16 June 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 39 (5) , 624-627
Suicide and depression in a patient with psoriasis receiving adalimumab: the role of the dermatologist
A 53‐year‐old man took his own life while receiving biological therapy with the tumour necrosis factor‐α inhibitor adalimumab for severe psoriasis. The patient had a psychiatric history and a 32‐year history of variable unstable psoriasis. Reported suicide in patients with psoriasis receiving adalimumab is rare (only one other reported case). It is important, however, to recognize the effects of skin disease on the mental health of vulnerable patients receiving biological agents. Patients will benefit from a more holistic approach that includes both dermatological and psychological assessment and treatment.
- 30 August 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 169 (3) , 607-610
Delusional infestation and patient adherence to treatment: an observational study
Delusional infestation (DI) is the persistent belief of pathogenic infestation of the skin or body, without objective medical evidence. Treatment for symptoms of delusions can be particularly challenging, especially when patients are difficult to engage and adverse to the possibility of a nonskin disorder. To date there has been no study to evaluate patient adherence to DI treatment. To assess the adherence of patients with DI to psychotropic and/or dermatological medication. Sixty-nine consecutive patients with DI receiving treatment from our psychodermatology clinic were identified from a departmental database. Patient adherence to treatment was assessed via medical records, patient letters and a telephone questionnaire. Eighteen of 69 patients were noncontactable, reducing the sample size to 51. Forty-nine of 51 patients were receiving psychotropic medication (96%). Psychotropic agents included second-generation antipsychotics and antidepressants. Twenty-nine of 49 patients were adherent to psychotropic medication. Secondary nonadherence was reported by 18 of 49 patients. Two patients were nonadherent to psychotropic medication. Adherence to dermatological medication was high (96%). This is the first study to assess the adherence of patients with DI to treatment. The majority of patients on psychotropic medication were compliant. Secondary nonadherence was mainly due to drug side-effects. The adherence to dermatological medications is high. Thorough counselling of patients with regard to indication, dosage and side-effects of psychotropic agents can improve adherence to medication and is an essential part of the treatment process for DI.
- 30 August 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 169 (3) , 607-610
Delusional infestation and patient adherence to treatment: an observational study
Delusional infestation (DI) is the persistent belief of pathogenic infestation of the skin or body, without objective medical evidence. Treatment for symptoms of delusions can be particularly challenging, especially when patients are difficult to engage and adverse to the possibility of a nonskin disorder. To date there has been no study to evaluate patient adherence to DI treatment. To assess the adherence of patients with DI to psychotropic and/or dermatological medication. Sixty-nine consecutive patients with DI receiving treatment from our psychodermatology clinic were identified from a departmental database. Patient adherence to treatment was assessed via medical records, patient letters and a telephone questionnaire. Eighteen of 69 patients were noncontactable, reducing the sample size to 51. Forty-nine of 51 patients were receiving psychotropic medication (96%). Psychotropic agents included second-generation antipsychotics and antidepressants. Twenty-nine of 49 patients were adherent to psychotropic medication. Secondary nonadherence was reported by 18 of 49 patients. Two patients were nonadherent to psychotropic medication. Adherence to dermatological medication was high (96%). This is the first study to assess the adherence of patients with DI to treatment. The majority of patients on psychotropic medication were compliant. Secondary nonadherence was mainly due to drug side-effects. The adherence to dermatological medications is high. Thorough counselling of patients with regard to indication, dosage and side-effects of psychotropic agents can improve adherence to medication and is an essential part of the treatment process for DI.